GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (LSE:AVO) » Definitions » Pretax Margin %

Advanced Oncotherapy (LSE:AVO) Pretax Margin % : % (As of Jun. 2022)


View and export this data going back to 2006. Start your Free Trial

What is Advanced Oncotherapy Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Advanced Oncotherapy's Pre-Tax Income for the six months ended in Jun. 2022 was £-15.95 Mil. Advanced Oncotherapy's Revenue for the six months ended in Jun. 2022 was £0.00 Mil. Therefore, Advanced Oncotherapy's pretax margin for the quarter that ended in Jun. 2022 was %.

The historical rank and industry rank for Advanced Oncotherapy's Pretax Margin % or its related term are showing as below:


LSE:AVO's Pretax Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.01
* Ranked among companies with meaningful Pretax Margin % only.

Advanced Oncotherapy Pretax Margin % Historical Data

The historical data trend for Advanced Oncotherapy's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Oncotherapy Pretax Margin % Chart

Advanced Oncotherapy Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Advanced Oncotherapy Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Advanced Oncotherapy's Pretax Margin %

For the Medical Devices subindustry, Advanced Oncotherapy's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Oncotherapy's Pretax Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Oncotherapy's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Advanced Oncotherapy's Pretax Margin % falls into.



Advanced Oncotherapy Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Advanced Oncotherapy's Pretax Margin for the fiscal year that ended in Dec. 2021 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-29.493/0
= %

Advanced Oncotherapy's Pretax Margin for the quarter that ended in Jun. 2022 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2022 )/Revenue (Q: Jun. 2022 )
=-15.953/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Advanced Oncotherapy  (LSE:AVO) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Advanced Oncotherapy Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Advanced Oncotherapy's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Oncotherapy (LSE:AVO) Business Description

Traded in Other Exchanges
N/A
Address
4 Tenterden Street, Third Floor, London, GBR, W1S 1TE
Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.